ΰεθψεβρθο 200

φεψϊ ξϊο

VAGINAL, PER OS

ξιπεο

Capsules

ωιξεω αϊψετδ

Vaginal administration: Progesterone substitution for ovary deprived women in situation of total progesterone deficiency. Supplementation of the luteal phase during in vitro fertilization cycles. Supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. In cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. For all other progesterone indication, in the case of : Adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. Vaginal or oral addministration: Disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).

ξρτψ ψιωεν

128 73 30719 00

ιφψο

Besins-international Laboratories, France

ϊεχσ ψιωιεο μϊψετδ

07/2013 - 07/2023

• δηξψδ μςμεο
• ςμεο μφψλο (ΰπβμιϊ)
• ςμεο μφψλο
• ςμεο μφψλο ; ςψαιϊ
• ςμεο μψετΰ

δερτϊ ϊβεαδ ηγωδ ων * λεϊψϊ * ςζεψ μπε μεεγΰ ωΰϊδ μΰ ψεαεθ δϊβεαδ ωμκ χιωεψιν ιδτλε αΰετο ΰεθεξθι μμηιφιν   αωμιηϊ ϊβεαδ ΰπι ξχαμ ΰϊ ϊπΰι δωιξεω αΰϊψ.